Literature DB >> 21227218

Updated concepts and treatment of carcinoma in situ.

D Lamm1, H Herr, G Jakse, M Kuroda, F K Mostofi, E Okajima, A Sakamoto, I Sesterhenn, F C da Silva.   

Abstract

Entities:  

Year:  1998        PMID： 21227218     DOI： 10.1016/s1078-1439(99)00020-4

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


× No keyword cloud information.
  9 in total

Review 1.  Management of carcinoma in situ of the bladder: best practice and recent developments.

Authors:  Dominic H Tang; Sam S Chang
Journal:  Ther Adv Urol       Date:  2015-12

2.  Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.

Authors:  Derek E Thomas; Hristos Z Kaimakliotis; Kevin R Rice; Jose A Pereira; Paul Johnston; Marietta L Moore; Angela Reed; Dylan M Cregar; Cindy Franklin; Rhoda L Loman; Michael O Koch; Richard Bihrle; Richard S Foster; Timothy A Masterson; Thomas A Gardner; Chandru P Sundaram; Charles R Powell; Stephen D W Beck; David J Grignon; Liang Cheng; Costantine Albany; Noah M Hahn
Journal:  Clin Genitourin Cancer       Date:  2016-11-30       Impact factor: 2.872

3.  Bladder cancer: narrowing the gap between evidence and practice.

Authors:  Maha H A Hussain; David P Wood; Dean F Bajorin; Bernard H Bochner; Robert Dreicer; Donald L Lamm; Michael A O'Donnell; Arlene O Siefker-Radtke; Dan Theodorescu; Colin P Dinney
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

4.  A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer.

Authors:  Colin B Josephson; Saleh Al-Azri; Daniel J Smyth; David Haase; B Lynn Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

5.  Bladder cancer: validating the EORTC risk tables in BCG-treated patients.

Authors:  David D Buethe; Wade J Sexton
Journal:  Nat Rev Urol       Date:  2011-08-16       Impact factor: 14.432

6.  Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.

Authors:  Daher C Chade; Shahrokh F Shariat; Guilherme Godoy; Caroline J Savage; Angel M Cronin; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Journal:  J Urol       Date:  2010-07       Impact factor: 7.450

7.  Postoperative C-reactive protein-to-albumin ratio predicts poor prognosis in patients with bladder cancer undergoing radial cystectomy.

Authors:  Kenji Kuroda; Shinsuke Tasaki; Akio Horiguchi; Keiichi Ito
Journal:  Mol Clin Oncol       Date:  2021-01-21

8.  Comparison of intravesical bacillus Calmette-Guerin and mitomycin C administration for non-muscle invasive bladder cancer: A meta-analysis and systematic review.

Authors:  Shang-Jun Jiang; Li-Yin Ye; Fan-Hua Meng
Journal:  Oncol Lett       Date:  2016-03-09       Impact factor: 2.967

Review 9.  Application of Mass Spectrometry Imaging in Uro-Oncology: Discovering Potential Biomarkers.

Authors:  Péter Czétány; Stefánia Gitta; András Balló; Alexandra Sulc; Gábor Máté; Árpád Szántó; László Márk
Journal:  Life (Basel)       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.